Prolactin Inhibition to Treat Postpartum Arrhythmic Storm

Prolactin Inhibition to Treat Postpartum Arrhythmic Storm

Postpartum electrical storm due to torsade de pointes is a rare but life-threatening condition. The uniqueness of this case lies in the use of cabergoline to suppress postpartum ventricular arrhythmias in absence of heart disease. Timely multidisciplinary management is crucial to achieve final diagn...

Full description

Bibliographic Details
Main Authors:	Miriam Compagnone, MD, Alessandro Marinelli, MD, Gianni Dall'Ara, MD, PhD, Matteo Ziacchi, MD, PhD, Simone Grotti, MD, Leonardo Ciurlanti, MD, Fabio Felice Tarantino, MD, Luciano Potena, MD, Mauro Biffi, MD, Marcello Galvani, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	JACC: Case Reports
Subjects:	arrhythmic storm cardiac arrest postpartum torsade de pointes
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666084923005685

Similar Items

Anti-arrhythmic medications increase non-cardiac mortality – A meta-analysis of randomized control trials
by: Bhavi Pandya, MBBS, et al.
Published: (2016-06-01)

Arrhythmic storm in postpartum lady with no structural heart disease: Case report with literature review
by: Neelam Chhabra, et al.
Published: (2021-05-01)

Electrical storm treated successfully in a patient with TANGO2 gene mutation and long QT syndrome: A case report
by: Frederico Scuotto, MD, CEPS-AC, et al.
Published: (2020-05-01)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
by: Ryota Kitajima, MD, et al.
Published: (2017-10-01)

The Resurfacing of Bepridil Hydrochloride on the World Stage as an Antiarrhythmic Drug for Atrial Fibrillation
by: Yuji Nakazato, MD, PhD
Published: (2009-01-01)

Suppression of cardiac memory–related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2
by: Sou Otsuki, MD, PhD, et al.
Published: (2020-07-01)

Immediate electrical storm of Torsades de Pointes after CRT-D implantation in an ischemic cardiomyopathy patient
by: Adnan Kaya, MD, et al.
Published: (2015-06-01)

Prevention of Torsade de Pointes during the Pharmacologic Treatment of Atrial Fibrillation
by: Hideo Mitamura, MD, PhD
Published: (2010-01-01)

Repolarization Injury and Occurrence of Torsades de Pointes During Acute Takotsubo Syndrome
by: Evangelia Vemmou, MD, et al.
Published: (2024-10-01)

An Automated Strategy for Early Risk Identification of Sudden Cardiac Death by Using Machine Learning Approach on Measurable Arrhythmic Risk Markers
by: Dakun Lai, et al.
Published: (2019-01-01)

Weathering the storm: Combining microaxial left ventricular assist device support with bilateral stellate ganglion blockade to treat recalcitrant ventricular tachycardia
by: Shriya Sharma, MBBS, et al.
Published: (2024-08-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
by: S. M. Komissarova, et al.
Published: (2021-05-01)

A case of short-coupled premature ventricular beat-induced ventricular fibrillation with early repolarization in the inferolateral leads
by: Hidekazu Kondo, MD, et al.
Published: (2015-02-01)

Torsades de Pointes
by: Richard J Chen, MD, et al.
Published: (2018-04-01)

Noncomplex ventricular arrhythmia associated with greater freedom from recurrent ectopy at 1 year after mitral repair surgeryCentral MessagePerspective
by: Dimosthenis Pandis, MD, MSc, et al.
Published: (2024-06-01)

Fragmented QRS on far‐field intracardiac electrograms as a predictor of arrhythmic events
by: Yuki Osaka, et al.
Published: (2021-10-01)

Atrioventricular block and pause-dependent torsade de pointes
by: Mustafa Dohadwala, MD, et al.
Published: (2017-02-01)

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
by: Egle Corrado, et al.
Published: (2020-08-01)

Balloon aortic valvuloplasty in high-risk patients: when the going gets tough, the tough get going
by: Gianni Dall’Ara, et al.
Published: (2022-12-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024-04-01)

INCREASE IN QTC DISPERSION PREDICTS ARRHYTHMIC EVENTS IN PATIENTS WITH CARDIAC RESYNCHRONIZATION THERAPY
by: Cuneyt Kocas, et al.
Published: (2014-04-01)

“Atrial torsades de pointes” Induced by Low-Energy Shock From Implantable-Cardioverter Defibrillator
by: Ilknur Can, MD, et al.
Published: (2013-09-01)

Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3
by: Reina Bianca Tan, MD, et al.
Published: (2017-01-01)

Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy
by: Linda T. Aaserud, MD, et al.
Published: (2024-10-01)

Wide QRS complex and the risk of major arrhythmic events in Brugada syndrome patients: A systematic review and meta‐analysis
by: Pattara Rattanawong, et al.
Published: (2020-02-01)

Sudden arrhythmic death in patients with syncope and implantable cardiac monitor
by: Pilar Cabanas Grandío, MD, PhD, et al.
Published: (2024-11-01)

Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
by: Maryam Saif Al Ali, et al.
Published: (2020-10-01)

Severe hypomagnesemia with secondary hypocalcaemia (HSH) presenting as recurrent self terminating Torsades de pointes
by: Manjappa Mahadevappa, MD, DM,, et al.
Published: (2020-09-01)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
by: Justin Z. Lee, MD, et al.
Published: (2021-12-01)

Torsades de pointes following vaccination for COVID-19
by: Victor A. Abrich, MD, FHRS, et al.
Published: (2022-06-01)

Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome
by: Akira Miyake, MD, et al.
Published: (2017-01-01)

Arrhythmic Risk Stratification in Non-ischemic Cardiomyopathy Based on Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis and Gray Zone Fibrosis
by: Daniel Hammersley, MD, et al.
Published: (2024-01-01)

The Era of Rhythm Control: A Review of the Epidemiology and Clinical Impact of Anti-Arrhythmic Medications in Atrial Fibrillation
by: Cicely Anne Dye, et al.
Published: (2023-03-01)

Congenital Long QT Syndrome, Coinciding With Cavitary Mycobacterium avium Lung Infection, Led to Cardiac Arrest
by: Muhammad Ghallab, MD, et al.
Published: (2023-11-01)

Arrhythmic Mitral Valve Prolapse: A Comprehensive Review
by: Yuyan Deng, et al.
Published: (2023-09-01)

Arrhythmic Mitral Valve Prolapse with Features of Mitral Annular Disjunction and Myocardial Tissue Changes as Assessed with Cardiac Magnetic Resonance
by: Elen Sahara, et al.
Published: (2025-01-01)

Spotlight on sudden arrhythmic death syndrome
by: Yuan D, et al.
Published: (2019-09-01)

Genetic Diagnostics Contribute to the Risk Stratification for Major Arrhythmic Events in Pediatric Patients with Long QT Syndrome Type 1–3
by: Tobias Burkard, et al.
Published: (2022-02-01)

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only?
by: Mauro Biffi, MD, et al.
Published: (2017-01-01)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
by: Zakariye Ashkir, MD, et al.
Published: (2024-01-01)